Cervarix offers HPV protection past 6 years, study shows

12/3/2009 | Yahoo!

A study that included almost 800 young women ages 15 to 25 found the new vaccine Cervarix offered protection against the human papillomavirus virus for longer than six years. Vaccine efficacy remained at 100% against 12-month persistent infection with HPV-16/18, the data showed.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX